European Commission OKs Agilent's Acquisition of Varian; FTC Approval Still Pending

The deal had been delayed as both the EC and the US Federal Trade Commission had questions concerning it.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.